Covaxin trials in children between 2 and 18 years to begin in 10-12 days
Tuesday, May 18th, 2021New Delhi: The Phase II/III clinical trials of Covaxin, indigenous COVID-19 vaccine, in the 2-18-year-olds will begin in the next 10-12 days, senior NITI Aayog member VK Paul announced Tuesday. The proposal was deliberated in Subject Expert Committee (SEC) (COVID-19) on May 11, the Health Ministry said last week. On May 13, India gave clearance […]